
Researchers Advance Development of Small-Molecule PAI-1 Inhibitors as Potential Strategy to Address Aging-Related Decline
A new scientific review is drawing renewed attention to plasminogen activator inhibitor-1 (PAI-1), a protein increasingly recognized for its role not only in blood clot